Safety of Deucravacitinib in Asian Patients
Dr. Ron Vender reviews the safety of deucravacitinib in Asian patients at WCD2023 in Singapore.
Safety of Deucravacitinib in Asian Patients
PASI Reductions for an Oral TYK2 Inhibitor
Long Term Efficacy of Deucravacitinib
Oral and Topical JAK Inhibitors
VIDEO: Study shows lower fertility rates in patients with moderate-to-severe plaque psoriasis
Phase II Trial for an Oral Peptide to Treat Plaque Psoriasis
Digital Dermatology and Artificial Intelligence
Speakers from the International Psoriasis Council